NeuroPace (NPCE)
(Delayed Data from NSDQ)
$7.46 USD
+0.07 (0.95%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $7.48 +0.02 (0.27%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum C VGM
Cash flow Statements
Fiscal Year End for NeuroPace, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -32.96 | -47.08 | -36.08 | -24.28 | -29.97 |
Depreciation/Amortization & Depletion | 0.46 | 0.53 | 0.56 | 3.80 | 2.86 |
Net Change from Assets/Liabilities | -1.03 | -2.07 | 0.37 | -2.07 | 0.01 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 13.83 | 11.76 | 10.57 | 0.93 | 2.08 |
Net Cash From Operating Activities | -19.70 | -36.87 | -24.58 | -21.61 | -25.03 |
Property & Equipment | -0.17 | -0.60 | -0.38 | -0.06 | -0.46 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 23.20 | 24.40 | -85.01 | -10.71 | 4.08 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 23.03 | 23.80 | -85.40 | -10.77 | 3.62 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 8.69 | 0.90 | 110.01 | 31.71 | 0.04 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | -4.09 | 11.93 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 12.54 | 21.33 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.56 | -0.41 | -3.39 | -1.16 | 0.00 |
Net Cash from Financing Activities | 8.13 | 0.49 | 102.53 | 55.01 | 21.37 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 11.45 | -12.58 | -7.45 | 22.63 | -0.04 |
Cash at Beginning of Period | 6.73 | 19.31 | 26.76 | 4.12 | 4.16 |
Cash at End of Period | 18.18 | 6.73 | 19.31 | 26.76 | 4.12 |
Diluted Net EPS | -1.27 | -1.91 | -2.17 | -117.85 | NA |
Fiscal Year End for NeuroPace, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -16.44 | -8.93 | -32.96 | -26.76 | -19.50 |
Depreciation/Amortization & Depletion | 0.24 | 0.12 | 0.46 | 0.34 | 0.23 |
Net Change from Assets/Liabilities | -2.23 | -2.27 | -1.03 | -0.63 | -2.16 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 7.01 | 3.54 | 13.83 | 10.68 | 7.37 |
Net Cash From Operating Activities | -11.43 | -7.53 | -19.70 | -16.36 | -14.06 |
Property & Equipment | -0.17 | -0.10 | -0.17 | -0.14 | -0.13 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 5.80 | 2.50 | 23.20 | 19.70 | 15.50 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 5.63 | 2.40 | 23.03 | 19.56 | 15.37 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 1.30 | 0.72 | 8.69 | 0.25 | 0.25 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.72 | -0.65 | -0.56 | -0.34 | -0.31 |
Net Cash from Financing Activities | 0.58 | 0.07 | 8.13 | -0.09 | -0.06 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -5.21 | -5.06 | 11.45 | 3.11 | 1.25 |
Cash at Beginning of Period | 18.18 | 18.18 | 6.73 | 6.73 | 6.73 |
Cash at End of Period | 12.97 | 13.12 | 18.18 | 9.84 | 7.98 |
Diluted Net EPS | -0.26 | -0.32 | -0.22 | -0.28 | -0.36 |